The EPI Health/Novan Trustee is initiating a voluntary recall of various within-expiry human drug products. The discontinuation of these post-marketing programs means the company will not be able to support or guarantee that the products will meet all intended specifications through the labeled shelf life of the product. Further distribution or use of any remaining product on the market should cease immediately.